Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/1999
09/14/1999US5952238 Method of assaying specimen substance by controlling dose of chemiluminescence
09/14/1999US5952228 Isolated cytolytic T cells which are specific for complexes OF HLA- B35 molecules and the peptide PHE Pro Ser Asp Ser Trp Cys Tyr PHE, and uses thereof
09/14/1999US5952224 Culturing cells with a concentration of an adhesion ligand (arginine-glycine-aspartic sequence), binding less than all adhesion surface receptors on the cells selecting cells able to grow, reculturing in higher concentrations of ligand
09/14/1999US5952223 Compositions for the diagnosis and treatment of Chediak-Higashi syndrome
09/14/1999US5952217 Recombinant yeast cell and assay using same
09/14/1999US5952214 Human growth-related CDC10 homolog
09/14/1999US5952212 Anticarcinogenic agents and antidiabetic agents
09/14/1999US5952211 Method for producing active human alanine aminotransferase
09/14/1999US5952202 Using internal control polynucleotide and primers, target polynucleotides and primers, non-extendable oligonucleotide complementary to the internal control primers, polymerase with exonuclease activity, self-quenching fluorescent probes
09/14/1999US5952201 Method of preparing oligonucleotide probes or primers, vector therefor and use thereof
09/14/1999US5952200 Removing fluid sample or feces from intestinal tract, extracting messenger rna, transcribing into complementary dna, amplifying dna by reverse-transcriptase polymerase chain reaction for the detection of small amounts of dna
09/14/1999US5952191 Method of growing several samples of microorganisms on a single flat surface of solid growth medium
09/14/1999US5952188 Reusable immobilized microbial composition useful as ready-to-use seed inoculum in BOD analysis
09/14/1999US5952186 Reagent, method, and kit for the quantitation of oxidation-reduction phenomena in proteins and peptides
09/14/1999US5952181 Hybridizing polynucleotide sequence to complementary polynucleotide forming a complex, detecting complex formation; anticarcinogenic agent, treatment of psychological disorders, alzheimer's disease
09/14/1999US5952180 Sets of labeled energy transfer fluorescent primers and their use in multi component analysis
09/14/1999US5952178 Methods for disease diagnosis from stool samples
09/14/1999US5952176 Glycosylase mediated detection of nucleotide sequences at candidate loci
09/14/1999US5952175 DNA encoding a human progesterone receptor complex p23-like protein
09/14/1999US5952174 Ligase/polymerase-mediated genetic bit analysis of single nucleotide polymorphisms and its use in genetic analysis
09/14/1999US5952173 Devices and methods utilizing arrays of structures for analyte capture
09/14/1999US5952172 Alternating current input signal to a hybridization complex with single stranded nucleic acid containing a covalently attached electron transfer moiety and electrode, detecting target sequence via output signal
09/14/1999US5952171 Ligating mammalian cdna to dna encoding alkaline phosphatase lacking signal sequences and membrane anchor sequences, transforming bacterial cells, isolating dna, transfecting mammal cells, isolating cdna clone expressing signal sequence
09/14/1999US5952170 Method for diagnosing cancers
09/14/1999US5952169 Identification of DNA-damaging substances by means of cell lines capable of overexpressing poly (ADP-ribose)--polymerase
09/14/1999US5952034 Increasing the digestibility of food proteins by thioredoxin reduction
09/14/1999US5952002 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
09/14/1999US5951979 Mutants (alanine replacing an aspartic acid) lack or have reduced catalytic activity but retain ability to bind substrate resulting in formation of observable and isolatable complex and less immunogenic effects
09/14/1999US5951965 Method for visually demonstrating the effectiveness of an anti-bacteria attachment composition
09/14/1999US5951836 Disposable glucose test strip and method and compositions for making same
09/14/1999CA2198125C Cytoplasmic male sterility system producing canola hybrids
09/14/1999CA2182511C Microbiological culture bottle, and method of making and using same
09/14/1999CA2170869C Amine-derivatized nucleosides and oligonucleosides
09/14/1999CA2132208C Method of eliminating inhibitory/instability regions of mrna
09/14/1999CA2071446C Synthetic catalytic oligonucleotide structures
09/14/1999CA1340749C Preparation and use of fluorescent benzothiazole derivatives
09/14/1999CA1340732C Sv40 expression vector containing hbxag as an expression marker
09/10/1999WO1999045392A1 Diagnostic for metastatic prostate cancer
09/10/1999WO1999045391A1 Membrane pore inhibiting agents for treating infection
09/10/1999WO1999045387A2 Electrochemical analyte sensor
09/10/1999WO1999045383A1 Genetic markers which identify individuals who decrease their blood pressure through exercise
09/10/1999WO1999045376A1 Method for regulating the sensitivity of a microsensor, and a microsensor that makes use of this method
09/10/1999WO1999045375A1 Process for producing an electrochemical biosensor
09/10/1999WO1999045357A2 Biosensor array comprising cell populations confined to microcavities
09/10/1999WO1999045155A2 Oligonucleotides for the amplification and detection of epstein barr virus (ebv) nucleic acid
09/10/1999WO1999045154A1 Production and use of normalized dna libraries
09/10/1999WO1999045153A2 An iterative and regenerative dna sequencing method
09/10/1999WO1999045152A1 Methods for identifying polycationic, peptide-like compounds with antibacterial activity
09/10/1999WO1999045151A1 Methods for detecting, selecting and cloning agents that degrade or promote degradation of dna
09/10/1999WO1999045150A1 Mass spectrometric methods for biomolecular screening
09/10/1999WO1999045149A1 Tagged ligand arrays for identifying ligand-target interactions
09/10/1999WO1999045148A1 Method for using a quality metric to assess the quality of biochemical separations
09/10/1999WO1999045147A1 A novel method of detecting and monitoring endometrial and uterine cancers
09/10/1999WO1999045146A1 Zymogenic nucleic acid detection methods, and related molecules and kits
09/10/1999WO1999045145A1 Screening for functional antisense agents
09/10/1999WO1999045144A1 Screening for functional antisense agents
09/10/1999WO1999045143A2 A fluorescence polarization screening method
09/10/1999WO1999045142A2 Agent and method for detecting chemical substances
09/10/1999WO1999045141A1 Multi-zone polymerase/ligase chain reaction
09/10/1999WO1999045140A1 Apparatus for monitoring a level of a chemical species in a body fluid
09/10/1999WO1999045139A1 Diagnostic assay for late-onset alzheimer's disease
09/10/1999WO1999045137A1 Method for determining antibiotic sensitivity of bacteria
09/10/1999WO1999045136A1 Methods for assaying type iii secretion inhibitors
09/10/1999WO1999045135A1 Novel fdrg protein and nucleic acid molecules and uses therefor
09/10/1999WO1999045115A1 Human synapse related glycoproteins (hsrp)
09/10/1999WO1999045110A1 V-like domain binding molecules
09/10/1999WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
09/10/1999WO1999045106A1 Cholesterol oxidase
09/10/1999WO1999045095A1 Disposable apparatus for determining antibiotic sensitivity of bacteria
09/10/1999WO1999045094A1 Selective cell analysis
09/10/1999WO1999045019A1 Isolated nucleic acid molecules which encode tage molecules, and uses thereof
09/10/1999WO1999035263A3 Il-17rh dna and polypeptides
09/10/1999WO1999032883A3 Embossed test strip system
09/10/1999WO1999032644A3 Prostate cancer gene
09/10/1999WO1999032617A3 Expression cloning in filamentous fungi
09/10/1999WO1999032514A3 Sag: sensitive to apoptosis gene
09/10/1999WO1999031236A3 EXTENDED cDNAs FOR SECRETED PROTEINS
09/10/1999WO1999029890A3 Assessment of human papilloma virus-related disease
09/10/1999WO1999028747A9 Methods for screening therapeutically effective agents
09/10/1999WO1999028466A9 Compositions and methods of use of het
09/10/1999WO1999027958A9 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
09/10/1999WO1999025829A3 Cdk2 protein and cdk2 protein complexes
09/10/1999WO1999025819A3 Antisense oligonucleotides against tenascin for treating vitiligo
09/10/1999WO1999025817A9 Tc1-based transposon vectors
09/10/1999WO1999023249A3 Specific and sensitive method for detecting nucleic acids
09/10/1999WO1998005356A8 NOVEL FtsL
09/10/1999CA2323229A1 Multi-zone polymerase/ligase chain reaction
09/10/1999CA2323171A1 Agent and method for detecting chemical substances
09/10/1999CA2322788A1 Tagged ligand arrays for identifying ligand-target interactions
09/10/1999CA2322621A1 V-like domain binding molecules
09/10/1999CA2322488A1 A fluorescence polarization screening method
09/10/1999CA2322426A1 Diagnostic for metastatic prostate cancer
09/10/1999CA2322425A1 Novel fdrg protein and nucleic acid molecules and uses therefor
09/10/1999CA2322381A1 Human synapse related glycoproteins (hsrp)
09/10/1999CA2322023A1 A novel method of detecting and monitoring endometrial and uterine cancers
09/10/1999CA2321948A1 Zymogenic nucleic acid detection methods, and related molecules and kits
09/10/1999CA2321931A1 Methods for identifying polycationic, peptide-like compounds with antibacterial activity
09/10/1999CA2321930A1 Production and use of normalized dna libraries
09/10/1999CA2321688A1 Method for determining antibiotic sensitivity of bacteria
09/10/1999CA2321686A1 Disposable apparatus for determining antibiotic sensitivity of bacteria